Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
IR-1061: NIR-II Fluorescent Dye Aggregation for Precision In
2026-05-14
Explore the molecular aggregation state of IR-1061, a leading near infrared fluorescent dye, and its pivotal role in deep tissue imaging and synergistic cancer therapy. This article uniquely analyzes the translation of H-aggregate engineering into practical assay design for biomedical research.
-
Clozapine N-oxide (CNO): Precision Chemogenetics for Neurona
2026-05-14
Clozapine N-oxide (CNO) stands out as a gold-standard chemogenetic actuator, enabling researchers to modulate neuronal activity with exceptional specificity. Recent advances, such as direct manipulation of cholecystokinin interneurons in the amygdala, showcase CNO’s pivotal role in dissecting complex behaviors and streamlining neuroscience research workflows.
-
Selective Autophagy Regulates IRF3 Stability in Antiviral Im
2026-05-13
Wu et al. (2021) uncover the critical role of selective autophagy, mediated by CALCOCO2/NDP52 and modulated by PSMD14, in controlling the degradation of transcription factor IRF3 and thus fine-tuning type I interferon production during viral infection. This study provides mechanistic insights into how innate immune responses are balanced at the molecular level, with direct implications for transcription factor regulation and immune homeostasis.
-
Annexin V-Cy5/DAPI Apoptosis Kit: Precision in Apoptosis Det
2026-05-13
Unlock rapid, dual-parameter apoptosis and necrosis analysis with the Annexin V-Cy5/DAPI Apoptosis Kit. This workflow-centric guide reveals performance-driven protocol optimizations and troubleshooting grounded in recent leukemia research, making it an indispensable tool for programmatic cell death studies.
-
Protoporphyrin IX: Applied Workflows in Photodynamic Researc
2026-05-12
Protoporphyrin IX stands at the nexus of heme biosynthesis and translational oncology, enabling reliable modeling of iron chelation and photodynamic therapy in cancer. This article delivers protocol-ready guidance, workflow enhancements, and troubleshooting tips to maximize reproducibility and clinical relevance in ferroptosis and photodynamic applications.
-
(R,S)-Anatabine: Optimizing Soluble Aβ Reduction Workflows
2026-05-12
(R,S)-Anatabine enables precise, dual-pathway targeting for soluble Aβ peptide reduction in both in vitro and in vivo Alzheimer's disease models. This article details robust protocol enhancements, troubleshooting advice, and actionable insights linking recent advances in epidermal barrier research to neurodegeneration workflows.
-
X-press Tag Peptide: Optimizing N-terminal Leader Peptide Wo
2026-05-11
The X-press Tag Peptide enables efficient, high-purity protein purification and detection in recombinant workflows, particularly for neddylation and mTORC1 pathway research. Its unique N-terminal leader peptide design, outstanding solubility, and compatibility with ProBond resin and antibody detection set a new benchmark for reproducibility and scalability in advanced proteomics.
-
α2-AR Agonist Hydrogel Strategy for Post-Surgical Osteosarco
2026-05-11
This study uncovers the utility of α2-adrenergic receptor agonists, administered via a thermo-sensitive hydrogel, in reducing immune rejection and tumor recurrence after osteosarcoma surgery. The findings highlight immune-mediated anti-tumor effects and provide a mechanistic rationale for targeting α2-AR signaling in post-surgical contexts.
-
Prostaglandin E2 in Inflammation Research: Protocols & Insig
2026-05-10
Prostaglandin E2 (PGE2) from APExBIO enables reproducible, high-sensitivity modulation of immune and gastrointestinal pathways in both classic and advanced inflammation research workflows. This guide delivers stepwise protocols, troubleshooting strategies, and translational insights, empowering researchers to extract maximum value from PGE2’s selective EP receptor targeting.
-
Machine Learning Unlocks Senolytic Discovery in Human Cell L
2026-05-09
This study demonstrates a machine learning-driven approach to identify novel senolytics, validated across multiple human cell models of senescence. The findings highlight the utility of AI in accelerating early-phase drug discovery and offer a blueprint for cost-effective compound screening in senescence and cancer research.
-
METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC
2026-05-08
Wang et al. (2024) identify a novel METTL16-SENP3-LTF regulatory axis that confers resistance to ferroptosis and promotes tumorigenesis in hepatocellular carcinoma (HCC). Their findings clarify how m6A RNA methylation, SUMOylation, and iron metabolism intersect to modulate HCC cell survival, revealing new therapeutic targets for sensitizing tumors to ferroptosis.
-
c-Myc tag Peptide: Mechanistic Insights and Precision in Imm
2026-05-08
Explore the c-Myc tag Peptide’s molecular mechanism and its unique impact on immunoassay precision. This article provides an advanced analysis of c-Myc Peptide applications, scientific rationale, and new technical perspectives unavailable elsewhere.
-
Balsalazide Disodium Dihydrate: Mechanism, Evidence, and Res
2026-05-07
Balsalazide disodium dihydrate is a water-soluble anti-inflammatory prodrug designed for targeted colonic activation. Its selectivity and pharmacokinetics make it highly suitable for ulcerative colitis and inflammation research, with robust evidence supporting its use as a radiotracer and immunology tool.
-
LY294002 in Tumor Immunology: Beyond PI3K Inhibition
2026-05-07
Explore how LY294002, a potent PI3K/Akt/mTOR signaling pathway inhibitor, advances tumor immunology research, with unique insights into macrophage polarization and experimental design. Discover nuanced protocol guidance and practical innovation beyond standard oncology applications.
-
SERCA-Driven ER Stress Enhances Hematopoietic Stem Cell Mobi
2026-05-06
Li et al. (2025) reveal that SERCA inhibition, via induction of mild endoplasmic reticulum (ER) stress, significantly enhances hematopoietic stem cell (HSC) mobilization by modulating the CaMKII-STAT3-CXCR4 pathway. These findings provide a new mechanistic understanding of how controlled ER stress can improve HSC transplantation outcomes.